SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 307 filers reported holding SEATTLE GENETICS INC in Q4 2018. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $4,054,000 | -1.6% | 41,024 | +69.1% | 0.01% | -14.3% |
Q2 2020 | $4,122,000 | +122.2% | 24,260 | +50.9% | 0.01% | -12.5% |
Q1 2020 | $1,855,000 | +69.9% | 16,073 | +68.2% | 0.02% | +128.6% |
Q4 2019 | $1,092,000 | +80.2% | 9,554 | +34.6% | 0.01% | +75.0% |
Q3 2019 | $606,000 | +21.4% | 7,100 | -1.7% | 0.00% | 0.0% |
Q2 2019 | $499,000 | -5.7% | 7,220 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $529,000 | +29.3% | 7,220 | 0.0% | 0.00% | -20.0% |
Q4 2018 | $409,000 | -52.6% | 7,220 | -35.5% | 0.01% | -28.6% |
Q3 2018 | $863,000 | +16.2% | 11,188 | 0.0% | 0.01% | +16.7% |
Q2 2018 | $743,000 | +26.8% | 11,188 | 0.0% | 0.01% | +20.0% |
Q1 2018 | $586,000 | -0.2% | 11,188 | +2.0% | 0.01% | 0.0% |
Q4 2017 | $587,000 | -1.7% | 10,968 | 0.0% | 0.01% | 0.0% |
Q3 2017 | $597,000 | -30.3% | 10,968 | -33.8% | 0.01% | -37.5% |
Q2 2017 | $856,000 | -80.6% | 16,558 | -76.4% | 0.01% | -80.0% |
Q1 2017 | $4,403,000 | +1126.5% | 70,057 | +929.0% | 0.04% | +900.0% |
Q4 2016 | $359,000 | – | 6,808 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 45,725,556 | $2,365,840,000 | 20.68% |
Lagoda Investment Management, L.P. | 398,529 | $20,620,000 | 7.88% |
Matrix Capital Management Company, LP | 2,118,000 | $109,585,000 | 3.72% |
Ghost Tree Capital, LLC | 300,000 | $15,522,000 | 3.23% |
Sio Capital Management, LLC | 100,000 | $5,174,000 | 2.46% |
GREAT POINT PARTNERS LLC | 249,500 | $12,909,000 | 2.31% |
Redmile Group, LLC | 665,139 | $34,414,000 | 2.10% |
Eventide Asset Management | 525,000 | $27,164,000 | 1.69% |
Opus Point Partners Management, LLC | 35,093 | $1,816,000 | 1.66% |
Boxer Capital, LLC | 125,000 | $6,468,000 | 1.54% |